Testing of Middle East Respiratory Syndrome Coronavirus Replication Inhibitors for the Ability To Block Viral Entry-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Testing of Middle East Respiratory Syndrome Coronavirus Replication Inhibitors for the Ability To Block Viral Entry

Published:2014-10-20 Issue:1 Volume:59 Page:742-744
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob. Agents Chemother.

Author:

Liu Qi,Xia Shuai,Sun Zhiwu,Wang Qian,Du Lanying,Lu Lu,Jiang Shibo

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference10 articles.

1. HIV-1 inhibition by a peptide;Nature,1993

2. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors;Lancet,2004

3. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor;Nat Commun,2014

4. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture;Antimicrob Agents Chemother,2014

5. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection;Antimicrob Agents Chemother,2014

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of natural alkaloid emetine against emerging COVID-19 and future viral pandemics;European Journal of Medicinal Chemistry Reports;2024-12

2. Ayurvedic and Chinese Herbs against Coronaviruses;Current Pharmaceutical Design;2024-06

3. Design of MERS-CoV entry inhibitory short peptides based on helix-stabilizing strategies;Bioorganic & Medicinal Chemistry Letters;2024-01

4. An overview of the recent progress in Middle East Respiratory Syndrome Coronavirus (MERS-CoV) drug discovery;Expert Opinion on Drug Discovery;2023-03-27

5. Rlip Protein: A Potential Target for COVID-19;Journal of Community Hospital Internal Medicine Perspectives;2022-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3